Biodegradable nanocarriers for small interfering ribonucleic acid (siRNA) co-delivery strategy incre...
Biodegradable nanocarriers for small interfering ribonucleic acid (siRNA) co-delivery strategy increase the chemosensitivity of pancreatic cancer cells to gemcitabine
About this item
Full title
Author / Creator
Publisher
Beijing: Tsinghua University Press
Journal title
Language
English
Formats
Publication information
Publisher
Beijing: Tsinghua University Press
Subjects
More information
Scope and Contents
Contents
Ribonucleic acid (RNA) interference (RNAi) therapies are promising cancer treatment modalities that can specifically target abnormal proto-oncogenes, thus improving the therapeutic effect. For the treatment of pancreatic cancer, targeting one mutant proto-oncogene by RNAi usually does not yield the desired therapeutic efficiency. Both K-ras gene mu...
Alternative Titles
Full title
Biodegradable nanocarriers for small interfering ribonucleic acid (siRNA) co-delivery strategy increase the chemosensitivity of pancreatic cancer cells to gemcitabine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2001468905
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2001468905
Other Identifiers
ISSN
1998-0124
E-ISSN
1998-0000
DOI
10.1007/s12274-017-1521-7
